Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Chronic Lymphocytic Leukemia and COVID-19: Scientific Achievements and Unmet Needs"
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Hematology".
Deadline for manuscript submissions: closed (15 March 2023) | Viewed by 2308
Special Issue Editor
Interests: chronic lymphocytic leukemia; chronic myeloproliferative neoplasms; clinical practice guidelines; evidence-based medicine; cost-effectiveness analysis; COVID-19
Special Issues, Collections and Topics in MDPI journals
Special Issue in Vaccines: Immunotherapy against Myeloma
Special Issue Information
Infections are a major hurdle for patients with chronic lymphocytic leukemia (CLL) and SARS-CoV2 was a difficult test bench for many of them. The interaction of several host-related and virus-related factors may impact onto the clinical outcomes of COVID-19. Moreover, therapies for CLL, vaccines, antivirals and monoclonal antibodies against SARS-CoV2 may also modulate the outcome. The present issue is devoted to clinical reporting of clinical and laboratory data pertaining the current scenario of care for CLL patients in a persisting pandemic era. We invite cohort studies, systematic reviews and biologic studies to be submitted.
Dr. Monia Marchetti
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- chronic lymphocytic leukemia